Corticosteroids (Prednisone)

Broad immunosuppression via NF-kB inhibition and anti-inflammatory gene transcription

Response rate
~60%
Onset
Days
Route
Oral 0.5-1 mg/kg/day; IV pulse for severe flares
Line
1st
IgM effect
Rapid ferritin reduction

Evidence summary

Mainstay of initial treatment, controlling about 60% of patients. High-dose regimens (1 mg/kg/day prednisone) are more effective than low-dose as first-line and may promote a monocyclic disease course. However, approximately 45% of patients develop steroid dependency, necessitating steroid-sparing agents. IV methylprednisolone pulses used for severe systemic disease and MAS.

Sources (3)

DetailsJamilloux Y et al. (2015) Treatment of adult-onset Still's disease: a review · Ther Clin Risk ManagPubMed
DetailsRuscitti P et al. (2019) Managing adult-onset Still's disease: the effectiveness of high-dosage of corticosteroids as first-line treatment · Clin Exp RheumatolPubMed
DetailsEfthimiou P et al. (2006) Diagnosis and management of adult onset Still's disease · Ann Rheum DisPubMed